01 6Otsuka Pharmaceutical Development & Commercialization, Inc
02 2Otsuka Pharmaceutical Development & Commercialization, Inc.
03 7Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
01 6No Action Indicated
02 9Voluntary Action Indicated
01 12024-03-22
02 12023-09-07
03 12023-02-27
04 12019-09-10
05 12018-11-14
06 12018-03-23
07 12017-02-03
08 12016-02-12
09 12014-11-19
10 12014-06-26
11 12014-03-18
12 22012-07-20
13 12012-07-09
14 12011-10-27
01 2Princeton
02 6Rockville
03 7Tokushima
01 7Japan
02 8U.S.A
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-03-22
City : Tokushima
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-03-22
District Decision : No Action Indicated
Inspection End Date : 2023-09-07
City : Rockville
State : Maryland
Country/Area : U.S.A
Zip : 20850
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2023-09-07
District Decision : No Action Indicated
Inspection End Date : 2023-02-27
City : Rockville
State : Maryland
Country/Area : U.S.A
Zip : 20850
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2023-02-27
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-10
City : Tokushima
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-10
District Decision : No Action Indicated
Inspection End Date : 2018-11-14
City : Rockville
State : Maryland
Country/Area : U.S.A
Zip : 20850
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2018-11-14
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-03-23
City : Tokushima
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-03-23
District Decision : No Action Indicated
Inspection End Date : 2017-02-03
City : Princeton
State : New Jersey
Country/Area : U.S.A
Zip : 8540
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2017-02-03
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-02-12
City : Tokushima
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-02-12
District Decision : No Action Indicated
Inspection End Date : 2014-11-19
City : Rockville
State : Maryland
Country/Area : U.S.A
Zip : 20850
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2014-11-19
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-26
City : Tokushima
State :
Country/Area : Japan
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-06-26
Otsuka Pharmaceutical is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find Aripiprazole bulk offered by Otsuka Pharmaceutical
Find Brexpiprazole bulk offered by Otsuka Pharmaceutical
Find Tolbabtan SD powder bulk offered by Otsuka Pharmaceutical
Find Tolbabtan spray-dried powder bulk offered by Otsuka Pharmaceutical
